Evidence map›Paper›PMID 41918367›Full record

ReviewAnnals of hepato-biliary-pancreatic surgery2026

Seeing the invisible: Three-dimensional liver modeling from simulation to the scalpel.

Serge Chooklin, Serhii Chuklin

Abstract readReview
In one paragraph

Review in Annals of hepato-biliary-pancreatic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Serge ChooklinSurgical Center, Saint Paraskeva Medical Center, Lviv, Ukraine.ORCID https://orcid.org/0000-0002-3503-8450
Serhii ChuklinSurgical Center, Saint Paraskeva Medical Center, Lviv, Ukraine.ORCID https://orcid.org/0000-0001-8979-721X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver resection requires precise, millimetric decisions within highly variable, patient-specific vascular and biliary anatomy. As the complexity of procedures increases (such as in major or extended hepatectomies, central lesions, and borderline future liver remnant scenarios), reliance on "2D cognition" can heighten the risk of planning errors and postoperative complications. This study aims to synthesize the role of 3D liver technologies, including digital visualization and planning, 3D printing, and intraoperative navigation (such as augmented reality and mixed reality), as a decision-making pipeline. This is a narrative, question-driven review of clinically relevant studies focused on liver resection workflows that utilize 3D visualization/planning, 3D printing, or intraoperative navigation. Across diverse studies, the most significant benefits of 3D planning are observed in anatomically complex or borderline cases. These benefits primarily enhance decision transparency and process-level endpoints (e.g., mapping, plan modifications, intraoperative orientation). However, consistent effects on morbidity and liver-specific outcomes are limited due to confounding factors and inconsistencies in endpoints. Augmented reality and mixed reality navigation face challenges related to registration stability and liver deformation, making uncertainty management and local accuracy reporting crucial. 3D printing appears most beneficial as a selective tool for high-stakes anatomy, as well as for communication and education, with feasibility influenced by time and cost considerations. "3D" should be assessed as an end-to-end measurement pipeline with explicit error budgets. Future studies should prespecify decision endpoints, standardize outcome definitions, and report task-relevant accuracy, particularly concerning navigation and critical biliary/vascular structures.

Indexed as

3-D printingAnatomic modelsAugmented realityComputer-assisted surgeryHepatectomy

Identifiers

PMID41918367
PMCPMC13212014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.